One of the listed companies, IBN SINA Pharmaceutical Industry PLC discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share Consolidated (EPS) was Tk 4.31 paisa in Q3 of the current financial year (January – March 24). Consolidated EPS was Tk 2.99 paisa during the same period last year. Consolidated NAV per share was Tk. 106.75 as of March 31, 2024.
Share this
